1. Home
  2. SRPT vs STEL Comparison

SRPT vs STEL Comparison

Compare SRPT & STEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • STEL
  • Stock Information
  • Founded
  • SRPT 1980
  • STEL 2007
  • Country
  • SRPT United States
  • STEL United States
  • Employees
  • SRPT N/A
  • STEL N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • STEL Major Banks
  • Sector
  • SRPT Health Care
  • STEL Finance
  • Exchange
  • SRPT Nasdaq
  • STEL Nasdaq
  • Market Cap
  • SRPT 1.9B
  • STEL 1.6B
  • IPO Year
  • SRPT 1997
  • STEL N/A
  • Fundamental
  • Price
  • SRPT $23.50
  • STEL $29.79
  • Analyst Decision
  • SRPT Hold
  • STEL Hold
  • Analyst Count
  • SRPT 31
  • STEL 3
  • Target Price
  • SRPT $40.61
  • STEL $31.00
  • AVG Volume (30 Days)
  • SRPT 6.1M
  • STEL 204.7K
  • Earning Date
  • SRPT 11-05-2025
  • STEL 10-24-2025
  • Dividend Yield
  • SRPT N/A
  • STEL 1.92%
  • EPS Growth
  • SRPT N/A
  • STEL N/A
  • EPS
  • SRPT N/A
  • STEL 2.08
  • Revenue
  • SRPT $2,481,531,000.00
  • STEL $425,008,000.00
  • Revenue This Year
  • SRPT $9.41
  • STEL N/A
  • Revenue Next Year
  • SRPT N/A
  • STEL $3.19
  • P/E Ratio
  • SRPT N/A
  • STEL $14.04
  • Revenue Growth
  • SRPT 64.89
  • STEL N/A
  • 52 Week Low
  • SRPT $10.42
  • STEL $24.13
  • 52 Week High
  • SRPT $138.81
  • STEL $32.38
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 62.33
  • STEL 45.69
  • Support Level
  • SRPT $21.93
  • STEL $28.51
  • Resistance Level
  • SRPT $23.87
  • STEL $31.40
  • Average True Range (ATR)
  • SRPT 1.42
  • STEL 0.84
  • MACD
  • SRPT 0.10
  • STEL -0.14
  • Stochastic Oscillator
  • SRPT 71.58
  • STEL 43.35

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About STEL Stellar Bancorp Inc.

Stellar Bancorp Inc is a U.S. based bank holding company. Through its subsidiary, Stellar Bank, the company provides a diversified range of commercial banking services predominantly to small to medium sized businesses, professionals, and individual customers. Its offerings include different types of loans, such as mortgage loans, home equity loans, automobile loans, etc.; deposit products, such as checking accounts, commercial accounts, money market accounts, savings accounts, etc.; and other banking services like mobile banking, debit cards, cash management and wire transfer services, letters of credit, and others.

Share on Social Networks: